Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03122912 · ClinicalTrials.gov registry record · Phase 1
Explore Effects of Dietary Fish Oil in Human Skin
A Phase 1 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT03122912: Clinical Trial Phase 1 study, sponsored by University of Michigan.
NCT03122912 is a Phase 1 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 17 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03122912, a Phase 1 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the potential differences in the skin of people who take fish oil versus soybean oil pills.
Primary Outcome
Barrier function will be measured at baseline and 16 weeks. Differences in barrier function between the two visits will be assessed.
Interventions
- DIETARY_SUPPLEMENT Fish Oil
- DIETARY_SUPPLEMENT Soybean Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-01-24 |
| Est. Completion | 2021-02-01 |
| Phase | Phase 1 |
Why NCT03122912 stopped before completion
NCT03122912 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 2 interventions - of which Fish Oil is the first listed.
NCT03122912 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03122912 about?
NCT03122912 is a clinical study titled "Explore Effects of Dietary Fish Oil in Human Skin". The purpose of this study is to explore the potential differences in the skin of people who take fish oil versus soybean oil pills.
What is the current status of trial NCT03122912?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2018-01-24. Estimated completion is 2021-02-01.
What interventions are being tested in trial NCT03122912?
The interventions under investigation include: Fish Oil (DIETARY_SUPPLEMENT), Soybean Oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03122912?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03122912's enrollment target sits among peer trials
17 1785th of 2000 higher than 215 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI